66592-72-1,MFCD00872034
Catalog No.:AA00FDNH

66592-72-1 | (2E,4E,6E,8E)-9-(3-hydroxy-2,6,6-trimethyl-1-cyclohexenyl)-3,7-dimethyl-nona-2,4,6,8-tetraenoic acid

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1mg
≥90%
in stock  
$570.00   $399.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA00FDNH
Chemical Name:
(2E,4E,6E,8E)-9-(3-hydroxy-2,6,6-trimethyl-1-cyclohexenyl)-3,7-dimethyl-nona-2,4,6,8-tetraenoic acid
CAS Number:
66592-72-1
Molecular Formula:
C20H28O3
Molecular Weight:
316.4345
MDL Number:
MFCD00872034
SMILES:
C/C(=C\C=C\C(=C\C(=O)O)\C)/C=C/C1=C(C)C(O)CCC1(C)C
Properties
Computed Properties
 
Complexity:
598  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0  
Defined Bond Stereocenter Count:
4  
Formal Charge:
0  
Heavy Atom Count:
23  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0  
Rotatable Bond Count:
5  
Undefined Atom Stereocenter Count:
1  
Undefined Bond Stereocenter Count:
0  
XLogP3:
4.5  

Literature

Title: Induction of CYP26A1 by metabolites of retinoic acid: evidence that CYP26A1 is an important enzyme in the elimination of active retinoids.

Journal: Molecular pharmacology 20150301

Title: The discovery of new coding alleles of human CYP26A1 that are potentially defective in the metabolism of all-trans retinoic acid and their assessment in a recombinant cDNA expression system.

Journal: Pharmacogenetics and genomics 20070301

Title: A novel cytochrome P450, zebrafish Cyp26D1, is involved in metabolism of all-trans retinoic acid.

Journal: Molecular endocrinology (Baltimore, Md.) 20060701

Title: The control of morphogen signalling: regulation of the synthesis and catabolism of retinoic acid in the developing embryo.

Journal: Developmental biology 20050901

Title: HPLC-MS/MS analysis of the products generated from all-trans-retinoic acid using recombinant human CYP26A.

Journal: Journal of lipid research 20020701

Title: Granulocytic differentiation of human NB4 promyelocytic leukemia cells induced by all-trans retinoic acid metabolites.

Journal: Cancer research 20010115

Title: Induction of the cytochrome P450 gene CYP26 during mucous cell differentiation of normal human tracheobronchial epithelial cells.

Journal: Molecular pharmacology 20000901

Title: Identification of human cytochrome P450 isoforms that contribute to all-trans-retinoic acid 4-hydroxylation.

Journal: Biochemical pharmacology 20000815

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:66592-72-1 Molecular Formula|66592-72-1 MDL|66592-72-1 SMILES|66592-72-1 (2E,4E,6E,8E)-9-(3-hydroxy-2,6,6-trimethyl-1-cyclohexenyl)-3,7-dimethyl-nona-2,4,6,8-tetraenoic acid
Catalog No.: AA00FDNH
66592-72-1,MFCD00872034
66592-72-1 | (2E,4E,6E,8E)-9-(3-hydroxy-2,6,6-trimethyl-1-cyclohexenyl)-3,7-dimethyl-nona-2,4,6,8-tetraenoic acid
Pack Size: 1mg
Purity: ≥90%
in stock
$570.00 $399.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA00FDNH
Chemical Name: (2E,4E,6E,8E)-9-(3-hydroxy-2,6,6-trimethyl-1-cyclohexenyl)-3,7-dimethyl-nona-2,4,6,8-tetraenoic acid
CAS Number: 66592-72-1
Molecular Formula: C20H28O3
Molecular Weight: 316.4345
MDL Number: MFCD00872034
SMILES: C/C(=C\C=C\C(=C\C(=O)O)\C)/C=C/C1=C(C)C(O)CCC1(C)C
Properties
Complexity: 598  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 0  
Defined Bond Stereocenter Count: 4  
Formal Charge: 0  
Heavy Atom Count: 23  
Hydrogen Bond Acceptor Count: 3  
Hydrogen Bond Donor Count: 2  
Isotope Atom Count: 0  
Rotatable Bond Count: 5  
Undefined Atom Stereocenter Count: 1  
Undefined Bond Stereocenter Count: 0  
XLogP3: 4.5  
Literature fold

Title: Induction of CYP26A1 by metabolites of retinoic acid: evidence that CYP26A1 is an important enzyme in the elimination of active retinoids.

Journal: Molecular pharmacology20150301

Title: The discovery of new coding alleles of human CYP26A1 that are potentially defective in the metabolism of all-trans retinoic acid and their assessment in a recombinant cDNA expression system.

Journal: Pharmacogenetics and genomics20070301

Title: A novel cytochrome P450, zebrafish Cyp26D1, is involved in metabolism of all-trans retinoic acid.

Journal: Molecular endocrinology (Baltimore, Md.)20060701

Title: The control of morphogen signalling: regulation of the synthesis and catabolism of retinoic acid in the developing embryo.

Journal: Developmental biology20050901

Title: HPLC-MS/MS analysis of the products generated from all-trans-retinoic acid using recombinant human CYP26A.

Journal: Journal of lipid research20020701

Title: Granulocytic differentiation of human NB4 promyelocytic leukemia cells induced by all-trans retinoic acid metabolites.

Journal: Cancer research20010115

Title: Induction of the cytochrome P450 gene CYP26 during mucous cell differentiation of normal human tracheobronchial epithelial cells.

Journal: Molecular pharmacology20000901

Title: Identification of human cytochrome P450 isoforms that contribute to all-trans-retinoic acid 4-hydroxylation.

Journal: Biochemical pharmacology20000815

Building Blocks More >
6630-99-5
6630-99-5
1,2,3,4-Thiatriazol-5-amine
AA00FDTZ | MFCD00159813
66129-60-0
66129-60-0
Ethyl 2-benzoyl-3-(dimethylamino)acrylate
AA00FE6T | MFCD00120477
714272-27-2
714272-27-2
Plinabulin(NPI-2358)
AA00FENP | MFCD18074510
6742-26-3
6742-26-3
Ethyl 1-oxo-1,2,3,4-tetrahydronaphthalene-2-carboxylate
AA00FFAA | MFCD00973033
7454-72-0
7454-72-0
4-bromo-N-(4-methoxyphenyl)benzenesulfonamide
AA00FFTF | MFCD00045022
693285-59-5
693285-59-5
3-bromo-2,4-dimethylbenzaldehyde
AA00FG4Q | MFCD22571466
676116-80-6
676116-80-6
7-Fluoro-4,4-dimethyl-1,3-dihydroquinolin-2-one
AA00FGFD | MFCD11040448
660440-56-2
660440-56-2
3-(4-Nitrophenyl)-1H-pyridin-2-one
AA00FGT6 | MFCD20491463
672-46-8
672-46-8
2-(Trifluoromethyl)pyrimidine-4,6-diamine
AA00FH0Z | MFCD09743717
70945-35-6
70945-35-6
8-methoxyquinolin-5-amine
AA00FHCZ | MFCD09044356
Submit
© 2017 AA BLOCKS, INC. All rights reserved.